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Histologic assessment and grading of the exocrine pancreas in the dog
S. J. Newman,1 J. M. Steiner, K. Woosley, D. A. Williams, L. Barton
Abstract. Histologic grading schemes for canine inflammatory conditions are sparse, and in the case of the
canine pancreas, have not been previously described. In a previous study, we determined that histologic lesions
of the exocrine pancreas occurred much more frequently than gross lesions. The intention of the current study
was to develop a histologic grading scheme for nonneoplastic lesions following extensive assessment of the
exocrine pancreas from dogs presented for necropsy examination. The parameters of the proposed scheme
include neutrophilic inflammation, lymphocytic inflammation, pancreatic necrosis, pancreatic fat necrosis, ede-
ma, fibrosis, atrophy, and hyperplastic nodules. In this case series, the most common lesion was pancreatic
hyperplastic nodules (80.2%), followed by lymphocytic inflammation (52.5%), fibrosis (49.5%), atrophy
(46.5%), neutrophilic inflammation (31.7%), pancreatic fat necrosis (25.7%), pancreatic necrosis (16.8%), and
edema (9.9%). Only 8 of the 101 animals had no evidence of any of the lesions in any of the sections examined.
Fibrosis, atrophy, and/or lymphocytic infiltration most commonly accompanied nodules. Neutrophilic inflam-
mation, when present, was often associated with necrosis (pancreatic necrosis, pancreatic fat necrosis, or both)
and occasionally with hyperplastic nodules. The utilization of a grading scheme for exocrine pancreatic lesions
will be useful in advancing the classification of exocrine pancreatic disease in the dog, which may lead to
multicenter studies of exocrine pancreatic disorders in the dog and in other species.
Key words: Canine; hyperplasia; inflammation; pancreas; pancreatitis.
Pancreatitis in dogs remains a significant and inad-
equately understood cause of morbidity and mortality.9
Accurate classification of pancreatitis in dogs is im-
portant not only for appropriate therapy of specific cas-
es but also for the study of pancreatitis through mul-
ticenter trials. Histologic grading schemes for canine
inflammatory conditions are sparse and, in the case of
the canine pancreas, have not been previously de-
scribed. Previous work by the authors determined that
histologic lesions of pancreatic inflammation and/or
necrosis occur more frequently in the dog than sus-
pected from either the clinical history or from grossly
recognizable lesions, and that these lesions do not lo-
calize to any particular region of the pancreas.6 This
supports the contention that lesions of the exocrine
pancreas could be easily overlooked at the time of ex-
ploratory laparotomy or during necropsy. A compre-
hensive assessment of pancreatic lesions in a large
number of dogs presented for necropsy was required
to characterize the type and extent of lesions and to
formulate a grading scheme. It is hoped that the fol-
lowing scheme can easily be adopted by pathologists
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and can ultimately form the basis for multi-institution-
al studies on canine exocrine pancreatic disease.
A total of 101 pancreata were collected consecu-
tively from dogs presented for necropsy examination
to the Pathology Department at the Animal Medical
Center (AMC), New York, New York. Study animals
included those with clinical signs compatible with pri-
mary pancreatic disease (such as vomiting, anorexia,
and abdominal pain) and those without. Inclusion cri-
teria consisted of having owner consent for necropsy
examination and having the pancreas removed in its
entirety within 6 hours of death. Fixation of the pan-
creas in 10% buffered formalin within this 6-hour pe-
riod minimized postmortem degeneration/autolysis of
the pancreatic tissue.6 The right limb of the pancreas
was identified with a suture at the time of removal.6
Pancreata were sectioned every 2 cm, beginning at the
tip of the right limb as described previously by these
authors (Fig. 1).6 Each transverse section was num-
bered so that the approximate location within the pan-
creas could be determined. These were then routinely
processed, stained with hematoxylin and eosin (HE),
and assessed with light microscopy by a single pa-
thologist (SJN).6
The histologic parameters of interest for character-
ization of lesions and development of a grading system
are defined below. Neutrophilic inflammation was de-
fined as the presence of neutrophils within the pancre-
atic parenchyma, peripancreatic adipose tissue, or both
(Fig. 2). Lymphocytic inflammation was defined as the
presence of variable numbers of lymphocytes and/or
plasma cells within the pancreatic parenchyma, inter-
116 Brief Communications
Figure 1. Pancreas; canine. Gross kodachrome with painted grid lines to demonstrate the 2-cm trimming technique used.
Figure 2. Pancreas; canine, 43495 P8. Example of grade III neutrophilic inflammation—hematoxylin and eosin (HE). Bar 5 150 mm.
Figure 3. Pancreas; canine, 43968 P1. Example of grade II lymphocytic inflammation (arrow; HE). There is accompanying fibrosis
and lobular atrophy and mild edema. Bar 5 225 mm.
Figure 4. Pancreas; canine, 44480 P1. Example of grade III necrosis (asterisk; HE). Bar 5 150 mm.
Figure 5. Pancreas; canine, 43953 P11. Example of grade II peripancreatic necrosis (HE). Bar 5 225 mm.
Figure 6. Pancreas; canine, 43940 P8. Example of grade II edema (asterisk; HE). Bar 5 150 mm.
Figure 7. Pancreas; canine, 43765, P12. Example of grade II fibrosis (arrow; HE). Bar 5 150 mm.
Figure 8. Pancreas; canine, 44032 P1, 43940 P1. Example of grade II atrophy (HE). There is accompanying fibrosis. Bar 5 100 mm.
Figure 9. Pancreas; canine,45324 P4. Example of grade II nodular hyperplasia (asterisk; HE). Bar 5 225 mm.
stitium, or both (Fig. 3). Pancreatic necrosis was de-
fined as coagulation necrosis of the pancreatic paren-
chyma (Fig. 4). Pancreatic fat necrosis was defined as
foci of saponification in the small remnants of peri-
pancreatic adipose tissue not removed at the time of
trimming (Fig. 5). Edema was defined as an expansion
of the interstitium by lightly eosinophilic proteina-
ceous fluid (Fig. 6). Fibrosis was defined as the pres-
ence of increased quantities of mature fibrous connec-
tive tissue that expanded the interstitium or replaced
portions of the acinar tissue (Fig. 7). Masson trichrome
staining was performed on any equivocal cases and
fibrous connective tissue was recognized as intense
blue-staining material. Atrophy was defined as a re-
duction in size of a pancreatic lobule or lobe, whereby
individual cells were fewer in number and smaller than
normal (Fig. 8). Occasionally, atrophic epithelial cells
were diffusely vacuolated. Finally, hyperplastic nod-
ules were defined as areas in which there were in-
creased numbers of variably sized, well-differentiated
exocrine pancreatic epithelial cells that were variably
demarcated and/or encapsulated from the surrounding
pancreatic parenchyma (Fig. 9).
The individual light microscopic slides were as-
sessed for all of the above-identified parameters and
subsequently graded based on the absence of (0) or
presence and severity (1, 2, or 3) of the specific lesion
in the section. Severity scores, for each section, were
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Table 1. Number of dogs with pancreatic lesions in each grade category.





























































defined as grade 1 (,10% of the section affected), 2
(10–40% of the section affected) and 3 (.40% of the
section affected). Additionally, a mean cumulative se-
verity score was assigned based on the number of sec-
tions and the severity score of each section (mean cu-
mulative score; MCS 5 S score of single sections/
number of sections). An MCS of .0.0 but less than
or equal to 1.0 was considered mild, an MCS of .1.0
but equal or less than 2.0 was considered moderate,
and an MCS of .2.0 was considered severe.
Also, the mean frequency score (MFS 5 [number
of slides that showed the particular lesion/total number
of slide examined] 3 100) was determined for each
pathologic parameter. Finally, an overall inflammatory
disease activity index and overall inflammatory dis-
ease chronicity index was calculated for each pancreas.
The disease activity index (AI) was calculated from
AI 5 (MCSneutrophilic inflammation 1 MCSlymphocytic inflammation 1
MCSpancreaticnecrosis 1 MCSperipancreaticnecrosis 1 MCSpancreatic
edema)/5, with a maximum AI of 3.0. An AI of .0.0 but
less than or equal to 1.0 was considered mild, an AI
of .1.0 but equal or less than 2.0 was considered mod-
erate, and an AI of .2.0 was considered severe. The
parameters comprising this index were of currently ac-
tive processes involving necrosis or inflammation. The
disease chronicity index (CI) was calculated from CI
5 (MCSfibrosis 1 MCSatrophy)/2, with a maximum CI of
3.0. The parameters comprising this index represented
varying degrees of severity of processes considered to
be more indicative of a chronic ongoing or previously
resolved pancreatic lesion. Similarly, a CI of .0.0 but
less than or equal to 1.0 was considered evidence of
a mild change of some duration, a CI of .1.0 but equal
or less than 2.0 was considered evidence of a moderate
change of some duration, and a CI of .2.0 was con-
sidered evidence of a severe change of some duration.
The number of dogs with lesions of each type and
severity, as well as mean cumulative and frequency
scores, are displayed in Table 1. In this case series, the
most common lesion was pancreatic hyperplastic nod-
ules (80.2%), followed by lymphocytic inflammation
(52.5%), fibrosis (49.5%), atrophy (46.5%), neutro-
philic inflammation (31.7%), pancreatic fat necrosis
(25.7%), pancreatic necrosis (16.8%), and edema
(9.9%). Fibrosis, atrophy, and/or lymphocytic infiltra-
tion most commonly accompanied nodules. Neutro-
philic inflammation, when present, was often associ-
ated with necrosis (pancreatic necrosis, pancreatic fat
necrosis, or both) and occasionally with hyperplastic
nodules.
Lymphocytic infiltrates varied in severity and, in the
most severe cases, were associated with the periduc-
tular interstitium and occasionally formed small nod-
ular/follicular structures. Mature connective tissue was
seen principally in the periductular interstitium and
less commonly associated with parenchymal damage.
Only in the more severe cases did the fibrous connec-
tive tissue encroach on pancreatic parenchyma. Occa-
sionally, fibrous connective tissue partially encapsu-
lated foci of exocrine nodular hyperplasia. Masson tri-
chrome stains failed to identify significant increases in
fibrous connective tissue in association with focal atro-
phic lobules. Pancreatic and peripancreatic necrosis
occurred concurrently in 12 cases (approximately 10%
of sections), and in 5 cases, pancreatic necrosis (3 dogs
with grade I and two dogs with grade II) occurred in
the absence of peripancreatic alterations. Rarely, both
locations for necrosis were seen in the same tissue sec-
tion (total number of sections that showed pancreatic
necrosis and peripancreatic fat necrosis 5 29). Edema
was a mild change and the least common alteration.
Fifteen animals had only 1 type of lesion, 15 had 2
types of lesions, 23 had 3 types of lesions, 17 had 4
types of lesions, 10 had 5 types of lesions, 7 had 6
types of lesions, 6 had 7 types of lesions, and none
had all 8 types of pancreatic lesions. Only 8 of the 101
animals had no evidence of any of the lesions in any
of the sections examined. Thus, most of the dogs had
3–4 different types of lesions.
AIs ranged from 0.0 to 1.2, with 70 of 101 (69.3%)
pancreata having a score .0.0, but only 2 pancreata
showing moderate lesions, and no pancreas showing
severe lesions. This suggests that the majority of the
pancreas submissions showed active lesions, although
mild. CIs ranged from 0.0 to 2.2, with 68 of 101
(67.3%) pancreata having a score of .0.0 but only 4
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pancreata showing signs of moderate chronicity, and
only 1 pancreas showing signs of severe chronicity.
This similarly suggests that the majority of pancreas
submissions showed lesions of some duration and of
slightly greater severity. A total of 11 pancreata had a
CI .0.0 but an AI of 0.0.
The variety of pancreatic lesions identified in this
series of cases was broad, extensive, and somewhat
unexpected. The random distribution of histologic pan-
creatic lesions documented previously6 would preclude
their identification without a thorough search. Un-
doubtedly, the extensive sectioning at 2-cm intervals
allowed us to detect a higher incidence of lesions than
might be expected from clinical parameters and which
might otherwise go undetected by gross examination
alone or by evaluation of a single histologic section
alone (as is the standard practice in most diagnostic
facilities). While examination of predetermined stan-
dard sites within a pancreas could be used for grading,
the differences in canine pancreatic size make consis-
tency and repeatability of sampling location difficult.
Although large dogs had more pancreatic sections ex-
amined, the MCS and MFS attempted to decrease the
significance of pancreatic size by a comparison of
means. The number of examined pancreatic slides
ranged from 5 for the smallest dog up to 31 for the
largest dog.
Pancreatic nodules were the most commonly noted
pancreatic change. We have published previously that
these nodules were not associated with prior injury but
that their frequency increased with advancing age.7
Additionally, these are apparently not preneoplastic
changes but rather represent an idiopathic hyperplasia.4
When they occurred in combination with other path-
ologic processes, fibrosis, atrophy, and lymphocytic in-
flammation were the most common type of lesions.
Less frequently, hyperplastic nodules occurred con-
currently with necrosis and neutrophilic inflammation.
The most common inflammatory lesion, lympho-
cytic inflammation, was mild in most cases. This could
help explain why histologic lesions may be more prev-
alent than clinical signs of pancreatic inflammation.
Lymphocytic inflammation was closely followed by fi-
brosis and atrophy as the most common changes. Pan-
creatic fibrosis has been determined to be an incidental
necropsy finding in dogs with normal digestive func-
tion.3 Fibrosis may indicate previous inflammatory ep-
isodes and resolved disease. Pancreatic fat necrosis
was usually accompanied by neutrophilic infiltration.
Hence, necrosis and neutrophilic inflammation oc-
curred at similar rates. Edema, though mild, was by
far the least common lesion noted but occasionally oc-
curred concurrently with acute neutrophilic inflam-
mation. The previously documented progression from
edema to fibrin deposition and leukocyte infiltration
was not noted in this study.1,2
Atrophy, when present, was mild; the majority of
the sections in which atrophy was detected were as-
signed a grade of I. Breeds (German Shepherds and
Rough-Coated Collies) predisposed to pancreatic aci-
nar atrophy (PAA) were not represented in this study
and the characteristic lesions of PAA were also not
apparent.8,10 Exocrine pancreatic insufficiency can be
the end result of chronic pancreatic inflammation.5
This case series demonstrates that histologic chang-
es in the canine pancreas are common. Although the
clinical significance of these lesions still needs to be
determined, the utilization of a grading scheme for
exocrine pancreatic lesions will permit better charac-
terization of exocrine pancreatic disease in the dog and
will facilitate multicenter studies of exocrine pancre-
atic disorders in the dog and other species.
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